LAUREN EITZMANN: Open Payments
NPI 1053993832 · BELLEVILLE, KS. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$296 in 17 payments from 11 companies in 2025. Trend: 2023 $330 · 2024 $221 · 2025 $296
Food & beverage: $296
| Company | Payments | Amount |
|---|---|---|
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 2 | $44 |
| Otsuka America Pharmaceutical, Inc. | 2 | $43 |
| ABBVIE INC. | 2 | $43 |
| Viatris Specialty LLC | 2 | $32 |
| Amgen Inc. | 2 | $28 |
| Electromed, Inc. | 2 | $24 |
| Corcept Therapeutics | 1 | $17 |
| Bayer Healthcare Pharmaceuticals Inc. | 1 | $17 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 1 | $16 |
| AstraZeneca Pharmaceuticals LP | 1 | $16 |
Products named: CAPLYTA, REXULTI, YUPELRI, EVENITY, SMARTVEST, VRAYLAR, QULIPTA, Korlym.
Industry payments across KS — which companies pay providers there.
